Additionally, in two independent cohorts of RA patients treated with disease-modifying antirheumatic drugs and/or glucocorticoids, Gal-3 levels were found to be reduced, likely because of treatment. This evidence concerns the gene LGALS3 and rheumatoid arthritis.